Dengue Testing Market by Type (Dengue IgG/IgM Rapid Test, ELISA-based Test, Real-Time RT-PCR Test), Component (Instruments & Equipments, Laboratory Consumables, Software & Data Management Solutions), End-User - Global Forecast 2024-2030

Dengue Testing Market by Type (Dengue IgG/IgM Rapid Test, ELISA-based Test, Real-Time RT-PCR Test), Component (Instruments & Equipments, Laboratory Consumables, Software & Data Management Solutions), End-User - Global Forecast 2024-2030


The Dengue Testing Market size was estimated at USD 499.78 million in 2023 and expected to reach USD 527.02 million in 2024, at a CAGR 5.71% to reach USD 737.69 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Dengue Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Dengue Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Dengue Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abnova Corporation, Biogenix Inc. Pvt. Ltd., Biolab Diagnostics {I}Pvt. Ltd., Biopanda Reagents Ltd., Certest Biotec, S.L., DiaSorin S.p.A., EUROIMMUN Medizinische Labordiagnostika AG, F. Hoffmann-La Roche Ltd., Getein Biotech, Inc., InBios International, Inc., Intec Products, Inc., Lexicare Pharma Pvt. Ltd., NovaTec Immundiagnostica GmbH, OriGene Technologies, Inc., Quest Diagnostics, Reckon Diagnostics Pvt. Ltd., Reliable Pro-detect Biomedicals Pvt. Ltd., Saheb Pharmaceuticals LLP, Sri Pharmacare, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Dengue Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
Dengue IgG/IgM Rapid Test

ELISA-based Test

Real-Time RT-PCR Test
Component
Instruments & Equipments

Laboratory Consumables

Software & Data Management Solutions
End-User
Diagnostic Centers

Hospitals

Research Institutes
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas

Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam

Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Dengue Testing Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Dengue Testing Market?
3. What are the technology trends and regulatory frameworks in the Dengue Testing Market?
4. What is the market share of the leading vendors in the Dengue Testing Market?
5. Which modes and strategic moves are suitable for entering the Dengue Testing Market?PDF E-mail From Publisher (2-5)Users License


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Dengue Testing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidences of dengue infections among population
5.1.1.2. Growing government initiatives promoting healthcare awareness
5.1.1.3. Rise in healthcare infrastructure and spendings across economies
5.1.2. Restraints
5.1.2.1. High costs associated with diagnostic kits and tests
5.1.3. Opportunities
5.1.3.1. Robust research and development of advanced dengue detection kits
5.1.3.2. Evolution of new testing model to swat mosquito-borne dengue fever
5.1.4. Challenges
5.1.4.1. Concerns over efficacy and effectiveness of existing testing methods
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Dengue Testing Market, by Type
6.1. Introduction
6.2. Dengue IgG/IgM Rapid Test
6.3. ELISA-based Test
6.4. Real-Time RT-PCR Test
7. Dengue Testing Market, by Component
7.1. Introduction
7.2. Instruments & Equipments
7.3. Laboratory Consumables
7.4. Software & Data Management Solutions
8. Dengue Testing Market, by End-User
8.1. Introduction
8.2. Diagnostic Centers
8.3. Hospitals
8.4. Research Institutes
9. Americas Dengue Testing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Dengue Testing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Dengue Testing Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Abbott Laboratories
13.1.2. Abnova Corporation
13.1.3. Biogenix Inc. Pvt. Ltd.
13.1.4. Biolab Diagnostics {I}Pvt. Ltd.
13.1.5. Biopanda Reagents Ltd.
13.1.6. Certest Biotec, S.L.
13.1.7. DiaSorin S.p.A.
13.1.8. EUROIMMUN Medizinische Labordiagnostika AG
13.1.9. F. Hoffmann-La Roche Ltd.
13.1.10. Getein Biotech, Inc.
13.1.11. InBios International, Inc.
13.1.12. Intec Products, Inc.
13.1.13. Lexicare Pharma Pvt. Ltd.
13.1.14. NovaTec Immundiagnostica GmbH
13.1.15. OriGene Technologies, Inc.
13.1.16. Quest Diagnostics
13.1.17. Reckon Diagnostics Pvt. Ltd.
13.1.18. Reliable Pro-detect Biomedicals Pvt. Ltd.
13.1.19. Saheb Pharmaceuticals LLP
13.1.20. Sri Pharmacare
13.1.21. Thermo Fisher Scientific Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
FIGURE 1. DENGUE TESTING MARKET RESEARCH PROCESS
FIGURE 2. DENGUE TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. DENGUE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. DENGUE TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. DENGUE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. DENGUE TESTING MARKET DYNAMICS
FIGURE 7. DENGUE TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. DENGUE TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. DENGUE TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
FIGURE 10. DENGUE TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. DENGUE TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. DENGUE TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS DENGUE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS DENGUE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES DENGUE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES DENGUE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC DENGUE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC DENGUE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. DENGUE TESTING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. DENGUE TESTING MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings